MAPT and Alzheimer disease: This would be critically important for AD and other neurologic conditions such as Parkinson’s Disease, Lewy Body dementia, Frontotemporal dementia, Amyotrophic Lateral Sclerosis, Corticobasal Disease, Stroke, Traumatic Brain Injury, and Multiple Sclerosis—all of which appear to be caused by the aggregation of soluble protein toxins in the brain (e.g., Aβ, tau, ɑ-synuclein, TDP-43, Huntingtin) into “oligomers” that then induce the pathogenesis of these neurologic diseases/conditions [46,47,48].